Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EXACT SCIENCES CORPORATION

(EXAS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about EXACT SCIENCES CORPORATION
01/18Exact Sciences Says Data for Second-Generation Cologuard Test Show Improved Specificity..
MT
01/10Exact Sciences' Q4 Revenue Outlook Beats Estimates But Caution Warranted on Screening B..
MT
01/10EXACT SCIENCES : Announces Preliminary Fourth Quarter 2021 Results - Form 8-K
PU
01/10Exact Sciences Provides Q4, Full-Year 2021 Revenue Guidance
MT
01/10Exact Sciences Acquires PreventionGenetics for $190 Million in Cash, Stock
MT
01/10Exact Sciences Corp. and OncXerna Therapeutics, Inc. Announce Licensing Agreement to He..
CI
01/10Exact Sciences Corporation Reports Preliminary Unaudited Revenue Guidance for the Fourt..
CI
01/09Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy ..
PR
01/09Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Can..
PR
01/09Exact Sciences Corporation acquired PreventionGenetics LLC for $190 million.
CI
01/03EXACT SCIENCES : Madison School Nurses Tour COVID-19 Lab
PU
01/03EXACT SCIENCES : Supporting Afghan Refugee Efforts
PU
01/03Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR
2021EXACT SCIENCES : Receives 2021 Climate Champion Awards
PU
2021EXACT SCIENCES : Commits $500,000 to Urban League Black Business Hub
PU
2021Exact Sciences Says New Data Back Clinical Value of Oncotype DX Breast Cancer Test; Sha..
MT
2021New Data Presented at SABCS« 2021 Strengthen Value of Oncotype DX Breast Recurrence Sco..
PR
2021Exact Sciences Corp. Announces New Data Presented At SABCS 2021 Strengthen Value of Onc..
CI
2021EXACT SCIENCES : Going the Extra Mile
PU
2021Exact Sciences Corp. Announces Data from the Rx for Positive Node, Endocrine Responsive..
CI
2021Publication in The New England Journal of Medicine Confirms that Tens of Thousands of W..
PR
2021EXACT SCIENCES : Presentation
PU
2021Exact Sciences Corporation and Pfizer Inc. Enter into an Amendment to the Amended & Res..
CI
2021Exact Sciences Says New Data in Clinically Low-Risk Prostate Cancer Patients Backs Use ..
MT
2021New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as Predicto..
PR
2021Exact Sciences Corporation Announces Publication of Results Underscoring the Importance..
CI
2021Exact Sciences Partners With Jefferson Health on Multi-Cancer Earlier Detection Test Re..
MT
2021Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Dete..
PR
2021Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Dete..
CI
2021NORTH AMERICAN MORNING BRIEFING : Stocks Futures -3-
DJ
2021INSIDER SELL : Exact Sciences
MT
2021BTIG Adjusts Exact Sciences' Price Target to $120 From $145, Reiterates Buy Rating
MT
2021Wells Fargo Adjusts Price Target on Exact Sciences to $95 From $120, Maintains Equal-We..
MT
2021Fresh data highlights strength of US economy ahead of Fed meeting
2021SVB Leerink Adjusts Exact Sciences' Price Target to $140 from $160, Keeps Outperform Ra..
MT
2021ANALYST RECOMMENDATIONS : Avis Budget, DuPont de Nemours, Ingredion, Lyft, T-Mobile US...
2021Phillips-Medisize and Exact Sciences Collaborate to Fight Colorectal Cancer
CI
2021Raymond James Lowers Exact Sciences to Outperform From Strong Buy, Price Target to $130..
MT
2021Exact Sciences Q3 Loss Narrows as Revenue Rises; Full-Year Revenue Outlook Updated
MT
2021EXACT SCIENCES : Q3 Earnings Snapshot
AQ
2021EXACT SCIENCES CORP Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021Exact Sciences Corporation Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Exact Sciences announces third quarter 2021 results - Form 8-K
PU
2021Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Reports Q3 Loss $-0.97, vs. Street Est..
MT
2021Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Reports Q3 Revenue $456.4M, vs. Street..
MT
2021Exact Sciences Corporation Revises Earnings Results for the Full Year 2021
CI
2021EARNINGS REACTION HISTORY : EXACT SCIENCES, 45.5% Follow-Through Indicator, 4.7% Sensitive
MT
2021Exact Sciences to participate in November investor conferences
PR
2021New Cologuard« Modeling Data Show Patient Navigation Matters When Reaching Underserved ..
PU
2021Exact Sciences Corp. Shares Data from Modeling Analyses that Demonstrate Cologuard
CI
2021TRACKINSIGHT : Cathie’s ARK fleet sails to green waters
TI
2021EXACT SCIENCES : Hosts Maydm Interns
PU
2021EXACT SCIENCES : schedules third quarter 2021 earnings call
PR
2021ONCOCYTE : Names Gisela Paulsen as Operations Chief
MT
2021INSIDER SELL : Exact Sciences
MT
2021EXACT SCIENCES : Hires Sales Employees From Pfizer for Cologuard Promotion; Shares Up
MT
2021Exact Sciences in Talks With Pfizer Amid Cologuard Sales-Force Changes
DJ
2021Exact Sciences Corporation and National Surgical Adjuvant Breast and Bowel Project Anno..
CI
2021EXACT SCIENCES : to Present New Oncotype DX Genomic Prostate Score« Test Data and Exhibit ..
PU
2021EXACT SCIENCES : to participate in September investor conferences
PR
2021RENALYTIX : Appoints Daniel J. Levangie to its Board of Directors
AQ
2021EXACT SCIENCES' : Cancer Test Related to Chemo Therapy Recommendations Gets Regulatory App..
MT
2021EXACT SCIENCES : receives regulatory approval for the Oncotype DX Breast Recurrence Score«..
PR
2021Exact Sciences Receives Regulatory Approval for the Oncotype DX Breast Recurrence Score..
CI
2021EXACT SCIENCES : Says Study Shows Its Liver Liquid Biopsy Test Delivers 82% Early-Stage Se..
MT
2021Exact Sciences Corp. Announces the Performance of its OncoguardÖ Liver Liquid Biopsy Te..
CI
2021Global markets live: Alibaba, Citigroup, Tyson Foods, Veoneer, Cisco...
2021MARKET CHATTER : Exact Sciences Reportedly Approached Invitae About Possible Merger
MT
2021Exact Sciences Approaches Invitae
CI
2021EXACT SCIENCES : Significant Insider Selling in Shares of Exact Sciences (EXAS) Continues
MT
2021INSIDER TRENDS : Exact Sciences Insider Extends 90-Day Selling Trend
MT
2021INSIDER TRENDS : Exact Sciences Insider Continues 90-Day Selling Trend
MT
2021INSIDER TRENDS : Exact Sciences Insider Extends 90-Day Selling Trend
MT
2021AFTER HOURS WATCH LIST SCORECARD : Lc, exas, irbt,
MT
2021EXACT SCIENCES : Baird Adjusts Price Target on Exact Sciences to $127 From $157, Keeps Out..
MT
1  2  3  4  5  6  7  8  9Next
Upcoming event on EXACT SCIENCES CORPORATION
02/24/22